Express Pharma - Page 814 of 2219 - Express Pharma

Diversifying beyond the US market

Rx-to-OTC Is only the beginning: Why some brands grow and others don’t

Zydus receives USFDA approval for generic Indocyanine Green for Injection

Angelini Pharma acquires Arvelle Therapeutics for $960 million

Brazilian Clinics plans deal with Bharat Biotech for five million doses of Covaxin

DoP issues revised public procurement guidelines

Drug activist group AIDAN raises concerns over EUA for COVAXIN

Reverse brain drain: Accelerated by COVID-19

Zydus Cadila gets DCGI approval for Phase Ill trial of ZyCoV-D

DCGI approves Covishield and Covaxin for restricted emergency use in India

NSRT to start Phase II trial of Eflornithine granules to treat COVID-19 by early Jan 2021

HMD gets WHO-PQS certification for 0.3 ml Kojak AD Syringe, required for Pfizer’s vaccine

COVAXIN clinical trials recruit 23,000 subjects